GMAB
Genmab A/S · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -13.3% ·
flujo de acciones -23.3% ·
nuevas posiciones netas -15.4%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 18.12K | $653,093 | n/a | n/a |
| Q2 2026 | 80 | +8 | 51.55M | $1.41B | +9 | −1 |
| Q1 2026 | 73 | -4 | 45.85M | $1.27B | +5 | −9 |
| Q4 2025 | 77 | 0 | 41.23M | $1.28B | n/a | n/a |
| Q3 2025 | 13 | -2 | 16.25M | $498.26M | n/a | −2 |
| Q2 2025 | 12 | +1 | 18.14M | $374.87M | +1 | n/a |
| Q1 2025 | 9 | 0 | 13.96M | $273.33M | n/a | n/a |
| Q4 2024 | 9 | 0 | 8.94M | $186.52M | +1 | −1 |
| Q3 2024 | 9 | -1 | 7.29M | $175.79M | n/a | −1 |
| Q2 2024 | 10 | n/a | 6.88M | $172.85M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Arrowstreet Capital ✦ | 3.64M | +5.5% | $111.74M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 3.45M | +9.0% | $105.83M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 3 | Renaissance Technologies ✦ | 2.82M | +2.0% | $86.54M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.67M | n/a | $51.36M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 5 | Two Sigma Investments ✦ | 1.39M | -14.1% | $42.67M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 1.12M | +64.5% | $34.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 7 | Goldman Sachs Group ✦ | 1.12M | n/a | $34.31M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 533.21K | -72.0% | $16.35M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | JPMorgan Chase ✦ | 236.36K | n/a | $7.25M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 10 | Millennium Management ✦ | 90.91K | -76.5% | $2.79M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 73.70K | +146.0% | $2.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 12 | Citadel Advisors ✦ | 51.47K | -98.6% | $1.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasivo) | 40.88K | +50.7% | $1.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Point72 Asset Management | $11.13M | era 0.0% |
| Baillie Gifford | $248 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 25.36K acciones, $6.69M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.